Rachel B. Jimenez MD

Dr. Jimenez is an Assistant Professor of Radiation Oncology at Harvard Medical School (HMS) and the Chair for Quality and Safety in the Department of Radiation Oncology at Massachusetts General Hospital. She holds an AB from Harvard University, an MD from Harvard Medical School, and completed her residency and chief residency training in the Harvard Radiation Oncology Program. She has also completed a Fellowship at HMS in Medical Ethics.

Her clinical practice focuses on the treatment of patients with breast cancer. She has special expertise in the use of proton radiation and the reduction of cardiac toxicity. She has also advanced the development of a tattoo-free treatment approach for women with breast cancer, the identification of biomarkers for breast cancer outcomes, and maximizing the quality of life in survivors. The latter includes optimizing the shoulder range of motion and outcomes after radiotherapy and breast reconstruction.  Dr. Jimenez is nationally recognized in the field of Radiation Oncology for the treatment of breast cancer. Her research has informed consensus guidelines and she has made novel contributions, specifically in the role of proton beam therapy for patients with breast cancer. She is the recipient of independent grant funding through the American Society of Clinical Oncology (ASCO), the American Cancer Society, and The Greenwall Foundation. She serves as the Principal Investigator of multiple clinical trials exploring the prevention of cardiac toxicity after breast radiotherapy.